VIRI - Virios Therapeutics' (VIRI) CEO Greg Duncan on Q2 2021 Results - Earnings Call Transcript
Virios Therapeutics Inc. (VIRI) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Angela Walsh - SVP of Finance, Secretary & Treasurer Greg Duncan - CEO & Chairman Conference Call Participants David Bautz - Zacks Small-Cap Research Presentation Operator Good morning, and welcome to Virios Therapeutics Second Quarter 2021 Financial Results Conference Call. Please be advised that today’s call is being recorded at the company's request. At this time, I'd like to turn the call over to Angela Walsh, SVP Finance, Treasurer of Virios Therapeutics. Please proceed, Angela. Angela Walsh Thank you. Good morning everyone and thank you for joining us on today's conference call. We are pleased to be with you today to discuss Virios Therapeutics second quarter financial results, as well as to provide you with an update on the operational progress we have made during the first six months of 2021. Please note
For further details see:
Virios Therapeutics' (VIRI) CEO Greg Duncan on Q2 2021 Results - Earnings Call Transcript